News

Read our latest news, and find more about us and our portfolio companies.

2019/02/11
Artios Pharma Announces Appointment of Professor Rajesh Chopra as Non-Executive Director

Artios Pharma Limited (Artios), a leading DNA Damage Response (DDR) company developing a broad pipeline of innovative treatments for cancer, today announced the appointment of Professor Rajesh Chopra as Non-Executive Director (NED)

2019/01/31
M&A of the Year: Prexton Therapeutics

Having emerged from the Merck Serono Entrepreneur Partnership Program (EPP) in 2015, Prexton Therapeutics raised a total $41m of funding before it was acquired by pharmaceutical firm Lundbeck for an estimated $1.1bn last year.

2019/01/16
ADC Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ADCT-601 in Advanced Solid Tumors

ADC Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ADCT-601 in Advanced Solid Tumors Pyrrolobenzodiazepine-based antibody drug conjugate targets AXL, a receptor tyrosine kinase highly expressed in solid tumors

2019/01/17
Asceneuron appoints Peter Van Vlasselaer as Chairman

Asceneuron appoints Peter Van Vlasselaer as Chairman Serial biotech entrepreneur joins leading small molecule tau modulation company